Topics in Companion Animal Medicine
Volume 24, Issue 3 , Pages 113-121 , August 2009

Update on Genomics in Veterinary Oncology

  • Matthew Breen, PhD, C. Biol, M. I. Biol

      Affiliations

    • Corresponding Author InformationAddress reprint requests to: Matthew Breen, PhD, C. Biol, M. I. Biol, Department of Molecular Biomedical Sciences, College of Veterinary Medicine, North Carolina Sate University, 4700 Hillsborough St, Raleigh, NC 27606

References 

  1. Centers for Disease Control and Prevention. Deaths: leading causes for 2002 (National Vital Statistics Reports 2005). 2002;
  2. Dorn CR, Taylor DO, Schneider R, et al. Survey of animal neoplasms in Alameda and Contra Costa Counties, California II (Cancer morbidity in dogs and cats from Alameda County). J Natl Cancer Inst. 1968;40(2):307–318
  3. Merlo DF, Rossi L, Pellegrino C, et al. Cancer incidence in pet dogs: findings of the Animal Tumor Registry of Genoa. Ital J Vet Intern Med. 2008;22(4):976–984
  4. Mack GS. Clinical trials going to the dogs: canine program to study tumor treatment, biology. J Natl Cancer Inst. 2006;98(3):161–162
  5. Khanna C, Lindblad-Toh K, Vail D, et al. The dog as a cancer model. Nat Biotechnol. 2006;24(9):1065–1066
  6. Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature. 2001;409(6822):860–921
  7. Lindblad-Toh K, Wade CM, Mikkelsen TS, et al. Genome sequence, comparative analysis and haplotype structure of the domestic dog. Nature. 2005;438(7069):803–819
  8. Pontius JU, Mullikin JC, Smith DR, et al. Initial sequence and comparative analysis of the cat genome. Genome Res. 2007;17(11):1675–1689
  9. O'Brien SJ, Johnson W, Driscoll C, et al. State of cat genomics. Trends Genet. 2008;24(6):268–279
  10. Oudejans JJ, van Wieringen WN, Smeets SJ, et al. Identification of genes putatively involved in the pathogenesis of diffuse large B-cell lymphomas by integrative genomics. Genes Chromosomes Cancer. 2009;48(3):250–260
  11. Nowell PC, Hungerford DA. A minute chromosome in human chronic granulocytic leukemia. Science. 1960;132:1497
  12. Rowley JD. A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. [letter] Nature. 1973;243(5405):290–293
  13. Kurzrock R, Kantarjian HM, Druker BJ, et al. Philadelphia chromosome-positive leukemias: from basic mechanisms to molecular therapeutics. Ann Intern Med. 2003;138(10):819–830
  14. Mauro MJ, Druker BJ. Chronic myelogenous leukemia. Curr Opin Oncol. 2001;13(1):3–7
  15. Mauro MJ, O'Dwyer ME, Druker BJ. ST1571, a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia: validating the promise of molecularly targeted therapy. Cancer Chemother Pharmacol. 2001;48(suppl 1):S77–S78
  16. Kantarjian HM, Talpaz M. Imatinib mesylate: clinical results in Philadelphia chromosome-positive leukemias. Semin Oncol. 2001;28(5 suppl 17):9–18
  17. Hernandez-Boluda JC, Cervantes F. Imatinib mesylate (Gleevec, Glivec): a new therapy for chronic myeloid leukemia and other malignancies. Drugs Today (Barc). 2002;38(9):601–613
  18. Deininger MW. Cytogenetic studies in patients on imatinib. Semin Hematol. 2003;40(2 Suppl 2):50–55
  19. Rosti G, Testoni N, Martinelli G, et al. The cytogenetic response as a surrogate marker of survival. Semin Hematol. 2003;40(2 suppl 2):56–61
  20. Tarrant JM, Stokol T, Blue JT, et al. Diagnosis of chronic myelogenous leukemia in a dog using morphologic, cytochemical, and flow cytometric techniques. Vet Clin Pathol. 2001;30(1):19–24
  21. Leifer CE, Matus RE, Patnaik AK, et al. Chronic myelogenous leukemia in the dog. J Am Vet Med Assoc. 1983;183(6):686–689
  22. Pollet L, Van Hove W, Mattheeuws D. Blastic crisis in chronic myelogenous leukaemia in a dog. J Small Anim Pract. 1978;19(8):469–475
  23. Breen M, Modiano JF. Evolutionarily conserved cytogenetic changes in hematological malignancies of dogs and humans—man and his best friend share more than companionship. Chromosome Res. 2008;16(1):145–154
  24. Thomas R, Duke SE, Karlsson EK, et al. A genome assembly-integrated dog 1 Mb BAC microarray: a cytogenetic resource for canine cancer studies and comparative genomic analysis. Cytogenet Genome Res. 2008;122(2):110–121
  25. Kisseberth WC, Nadella MV, Breen M, et al. A novel canine lymphoma cell line: a translational and comparative model for lymphoma research. Leuk Res. 2007;31(12):1709–1720
  26. Thomas R, Wang HJ, Tsai PC, et al. Influence of genetic background on tumor karyotypes: evidence for breed-associated cytogenetic aberrations in canine appendicular osteosarcoma. Chromosome Res. 2009;in press
  27. Lin TY, Thomas R, Tsai PC, et al. Generation and characterization of novel canine malignant mast cell line CL1. Vet Immunol Immunopathol. 2009;127(1-2):114–124
  28. Chen WK, Swartz JD, Rush LJ, et al. Mapping DNA structural variation in dogs. Genome Res. 2008;
  29. Thomson SA, Kennerly E, Olby N, et al. Microarray analysis of differentially expressed genes of primary tumors in the canine central nervous system. Vet Pathol. 2005;42(5):550–558
  30. Khanna C, Wan X, Bose S, et al. The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med. 2004;10(2):182–186
  31. Hayashita Y, Osada H, Tatematsu Y, et al. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res. 2005;65(21):9628–9632
  32. Aguda BD, Kim Y, Piper-Hunter MG, et al. MicroRNA regulation of a cancer network: consequences of the feedback loops involving miR-17-92, E2F, and Myc. Proc Natl Acad Sci U S A. 2008;105(50):19678–19683
  33. Mendell JT. miRiad roles for the miR-17-92 cluster in development and disease. Cell. 2008;133(2):217–222
  34. Takakura S, Mitsutake N, Nakashima M, et al. Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cells. Cancer Sci. 2008;99(6):1147–1154
  35. Boggs RM, Moody JA, Long CR, et al. Identification, amplification and characterization of miR-17-92 from canine tissue. Gene. 2007;404(1-2):25–30
  36. Castoldi M, Schmidt S, Benes V, et al. miChip: an array-based method for microRNA expression profiling using locked nucleic acid capture probes. Nat Protoc. 2008;3(2):321–329
  37. Krichevsky AM, King KS, Donahue CP, et al. A microRNA array reveals extensive regulation of microRNAs during brain development. RNA. 2003;9(10):1274–1281
  38. Zhang X, Chen J, Radcliffe T, et al. An array-based analysis of microRNA expression comparing matched frozen and formalin-fixed paraffin-embedded human tissue samples. J Mol Diagn. 2008;10(6):513–519
  39. Jay C, Nemunaitis J, Chen P, et al. miRNA profiling for diagnosis and prognosis of human cancer. DNA Cell Biol. 2007;26(5):293–300
  40. Sutter NB, Ostrander EA. Dog star rising: the canine genetic system. Nat Rev Genet. 2004;5(12):900–910
  41. Sutter NB, Bustamante CD, Chase K, et al. A single IGF1 allele is a major determinant of small size in dogs. Science. 2007;316(5821):112–115
  42. Karlsson EK, Lindblad-Toh K. Leader of the pack: gene mapping in dogs and other model organisms. Nat Rev Genet. 2008;9(9):713–725
  43. Drogemuller C, Karlsson EK, Hytonen MK, et al. A mutation in hairless dogs implicates FOXI3 in ectodermal development. Science. 2008;321(5895):1462
  44. Jones P, Chase K, Martin A, et al. Single-nucleotide-polymorphism-based association mapping of dog stereotypes. Genetics. 2008;179(2):1033–1044

PII: S1938-9736(09)00018-X

doi: 10.1053/j.tcam.2009.03.002

Topics in Companion Animal Medicine
Volume 24, Issue 3 , Pages 113-121 , August 2009

Article Tools

* Image Usage & Resolution